Literature DB >> 1850542

Chronic fatigue syndrome in northern Nevada.

S A Daugherty1, B E Henry, D L Peterson, R L Swarts, S Bastien, R S Thomas.   

Abstract

The clinical and laboratory findings from studies of patients with chronic fatigue syndrome (CFS) from northern Nevada are summarized. Physicians caring for these patients have estimated that greater than 400 patients with CFS from northern Nevada and nearby communities in California were identified between 1984 and 1988. As a result of these studies, a cluster of clinical and laboratory features associated with the illness in moderately to severely affected patients has been identified: profound fatigue of prolonged duration; cervical lymphadenopathy; recurrent sore throat and/or symptoms of influenza; loss of cognitive function manifested by loss of memory and loss of ability to concentrate; myalgia; impairment of fine motor skills; abnormal findings on magnetic resonance imaging brain scan; depressed level of antibody to Epstein-Barr virus (EBV) nuclear antigen; elevated level of antibody to EBV early antigen restricted component; elevated ratio of CD4 helper to CD8 suppressor cells; and strong evidence of association of this syndrome with infection with human herpesvirus 6. More-serious and longer-lasting neurologic impairments, including seizures, psychosis, and dementia, have also been observed in some of these patients.

Entities:  

Mesh:

Year:  1991        PMID: 1850542     DOI: 10.1093/clinids/13.supplement_1.s39

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  15 in total

Review 1.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Immune responsiveness in chronic fatigue syndrome.

Authors:  C Shepherd
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

3.  Neuroimaging in chronic fatigue syndrome.

Authors:  H Cope; A S David
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

Review 4.  Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.

Authors:  Liisa K Selin; Myriam F Wlodarczyk; Anke R Kraft; Siwei Nie; Laurie L Kenney; Roberto Puzone; Franco Celada
Journal:  Autoimmunity       Date:  2011-01-20       Impact factor: 2.815

5.  Development and application of a high-throughput microneutralization assay: lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors.

Authors:  Yanchen Zhou; Imke Steffen; Leilani Montalvo; Tzong-Hae Lee; Reeve Zemel; William M Switzer; Shaohua Tang; Hongwei Jia; Walid Heneine; Valerie Winkelman; Chetankumar S Tailor; Yasuhiro Ikeda; Graham Simmons
Journal:  Transfusion       Date:  2012-02       Impact factor: 3.157

6.  Characteristics of chronic fatigue syndrome in a Japanese community population : chronic fatigue syndrome in Japan.

Authors:  Masahide Hamaguchi; Yutaka Kawahito; Noriyuki Takeda; Takahiro Kato; Takao Kojima
Journal:  Clin Rheumatol       Date:  2011-02-08       Impact factor: 2.980

7.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

8.  Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort.

Authors:  Frank J M van Kuppeveld; Arjan S de Jong; Kjerstin H Lanke; Gerald W Verhaegh; Willem J G Melchers; Caroline M A Swanink; Gijs Bleijenberg; Mihai G Netea; Jochem M D Galama; Jos W M van der Meer
Journal:  BMJ       Date:  2010-02-25

Review 9.  Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis.

Authors:  Zohara Sternberg
Journal:  Neuromolecular Med       Date:  2015-10-26       Impact factor: 3.843

10.  Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) in Familial Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Alexander P Sung; Jennifer J-J Tang; Michael J Guglielmo; Julie Smith-Gagen; Lucinda Bateman; Lydia Navarrete-Galvan; Doug D Redelman; Dorothy Hudig
Journal:  Fatigue       Date:  2021-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.